Corbus Pharmaceuticals Hldgs Inc (CRBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -40,209 | -44,604 | -42,347 | -45,640 | -111,269 |
| Depreciation Amortization | -2,343 | 959 | 1,630 | 3,038 | 1,986 |
| Accounts payable and accrued liabilities | 1,603 | 1,028 | -257 | -5,956 | -3,469 |
| Other Working Capital | -5,576 | 4,094 | -3,299 | -15,697 | -3,205 |
| Other Operating Activity | 4,731 | 2,423 | 6,728 | 16,071 | 16,272 |
| Operating Cash Flow | $-41,794 | $-36,100 | $-37,544 | $-48,184 | $-99,686 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -121,310 | 35,642 | 30,080 | -73,386 | N/A |
| PPE Investments | N/A | N/A | -5 | -30 | -485 |
| Investing Cash Flow | $-121,310 | $35,642 | $30,074 | $-73,417 | $-485 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 373 | 1,834 | 984 | 19,665 |
| Debt Repayment | -15,480 | -3,247 | -2,368 | N/A | N/A |
| Common Stock Issued | 182,058 | 53 | N/A | 62,586 | 142,201 |
| Other Financing Activity | 0 | 0 | 0 | -2,747 | -6,991 |
| Financing Cash Flow | $166,578 | $-2,821 | $-534 | $60,823 | $154,875 |
| Beginning Cash Position | 14,394 | 17,673 | 25,677 | 86,453 | 31,749 |
| End Cash Position | 17,868 | 14,394 | 17,673 | 25,677 | 86,453 |
| Net Cash Flow | $3,474 | $-3,279 | $-8,004 | $-60,777 | $54,705 |
| Free Cash Flow | |||||
| Operating Cash Flow | -41,794 | -36,100 | -37,544 | -48,184 | -99,686 |
| Capital Expenditure | N/A | N/A | -13 | -54 | -485 |
| Free Cash Flow | -41,794 | -36,100 | -37,558 | -48,238 | -100,170 |